Nexium Capsules RE Maintenance Specific Clinical Experience Investigation

Nexium (Esomeprazole) in Symptom Adapted Therapy in GERD Patients

NCT00444275 ·Status: COMPLETED ·Phase: PHASE4

An Open-Label Study of Once-Daily Oral Administration of Esomeprazole 40 mg in Patients With Symptoms of Gastroesophageal Reflux Disease (GERD)

NCT00242736 ·Status: COMPLETED ·Phase: PHASE4

Reflux Esophagitis Phase III Study (Maintenance Treatment)

NCT00634114 ·Status: COMPLETED ·Phase: PHASE3

Pharmacodynamic and Pharmacokinetic Study of E3710 Following Oral Administration to Healthy, Male, Japanese Subjects

NCT01390714 ·Status: COMPLETED ·Phase: PHASE1

Comparison of Nexium Versus Secretol in the Healing and Controlling of Symptoms in GERD Patients With Severe EE.

NCT01129713 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Survey Examining the Frequency and Severity of Acid Related Symptoms While Taking Nexium

NCT01130935 ·Status: COMPLETED

Nexium 40mg Once Daily vs Prevacid 30mg Twice a Day for Control of Severe GERD

NCT00295685 ·Status: COMPLETED ·Phase: PHASE4

Adult Asthmatics and Acid Reflux

NCT00628953 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Study to Determine Anti-Asthmatic Effect of Esomeprazole Magnesium; Nexium Reflux Asthma

NCT00317044 ·Status: COMPLETED ·Phase: PHASE2

Reflux Esophagitis Phase III Study (Initial Treatment)

NCT00633932 ·Status: COMPLETED ·Phase: PHASE3

PPI Test in GP Patients

NCT00318084 ·Status: COMPLETED ·Phase: PHASE4

Drug Interaction Study Between AZD3355 and Nexium

NCT00684190 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Effect on 24-hour, Intragastric pH of RAB ER 50-mg Capsules Compared With Esomeprazole (Nexium) 40 mg Capsules and Rabeprazole (Aciphex) 20-mg Tablets

NCT01153659 ·Status: COMPLETED ·Phase: PHASE1

A Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Related Diseases

NCT02153398 ·Status: COMPLETED ·Phase: PHASE3

NEXIUM® in the Treatment of Moderate and Severe Erosive Esophagitis

NCT00206180 ·Status: COMPLETED ·Phase: PHASE4

An Open, Randomized, Two Way Crossover Study Comparing the Effect of 20mg Esomeprazole Administered Orally and Intravenously as a 15 Minute Infusion on Basal and Pentagastrin-Stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD)

NCT00629564 ·Status: COMPLETED ·Phase: PHASE4

Study to Assess Management Strategies for the Use of Esomeprazole (Nexium) in Helicobacter Pylori Infected Patients

NCT00574925 ·Status: COMPLETED ·Phase: PHASE4

Pharmacokinetic and Safety of Dexlansoprazole in Adolescents With Gastroesophageal Reflux Disease

NCT00847210 ·Status: COMPLETED ·Phase: PHASE1

A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is Continued

NCT00633672 ·Status: COMPLETED ·Phase: PHASE3

Nexium RESPONSE Trial

NCT00318968 ·Status: COMPLETED ·Phase: PHASE4

The Efficacy of Double Doses of Oral Esomeprazole in Preventing Rebleeding for Patients With Bleeding Peptic Ulcers

NCT01591083 ·Status: COMPLETED ·Phase: PHASE4

Study to Assess the Pharmacodynamics/Pharmacokinetics After Repeated Dosing of D961H 10 mg and Omeprazole 10 mg in Japanese Healthy Male Subjects

NCT01159145 ·Status: COMPLETED ·Phase: PHASE1

Esomeprazole (NEXIUM) vs. Surgery

NCT00251927 ·Status: COMPLETED ·Phase: PHASE3

Open, Randomized, Two Way Crossover Study Comparing the Effect of Esomeprazole Adminstered Orally and iv

NCT00626262 ·Status: COMPLETED ·Phase: PHASE4

Open, Randomized, Two Way Crossover 40mg, Orally and Intravenously

NCT00635414 ·Status: COMPLETED ·Phase: PHASE4